Diploma’s (DPLM) “Buy” Rating Reaffirmed at Berenberg Bank

Berenberg Bank reaffirmed their buy rating on shares of Diploma (LON:DPLM) in a research note released on Monday morning, Marketbeat Ratings reports. The firm currently has a GBX 9,000 target price on the stock.

DPLM has been the subject of several other reports. JPMorgan Chase & Co. lifted their price target on shares of Diploma from GBX 5,120 to GBX 5,760 and gave the company a “neutral” rating in a research note on Friday, March 27th. Royal Bank Of Canada increased their price objective on shares of Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a research report on Friday. Jefferies Financial Group reissued a “hold” rating and set a GBX 7,000 price objective on shares of Diploma in a research report on Friday, May 29th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research note on Wednesday, May 20th. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 7,044.29.

Diploma Stock Performance

Shares of DPLM stock opened at GBX 7,370 on Monday. The firm has a 50 day moving average of GBX 6,979.65 and a 200-day moving average of GBX 6,257.69. The company has a market cap of £9.88 billion, a price-to-earnings ratio of 52.34, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92. The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 47.65. Diploma has a 52 week low of GBX 4,970 and a 52 week high of GBX 7,663.22.

Diploma (LON:DPLM) last released its earnings results on Tuesday, May 19th. The company reported GBX 74.70 earnings per share (EPS) for the quarter. The company had revenue of £851.10 million for the quarter. Diploma had a net margin of 9.42% and a return on equity of 18.55%. On average, equities analysts forecast that Diploma will post 163.7995512 earnings per share for the current year.

Insider Buying and Selling at Diploma

In other Diploma news, insider Mandy Gradden acquired 1,000 shares of Diploma stock in a transaction dated Friday, July 17th. The stock was purchased at an average cost of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Katie Bickerstaffe  acquired 177 shares of Diploma stock in a transaction dated Wednesday, May 20th. The shares were acquired at an average price of GBX 6,730 per share, with a total value of £11,912.10. Over the last three months, insiders have acquired 1,781 shares of company stock valued at $12,638,928. Corporate insiders own 1.14% of the company’s stock.

Diploma News Roundup

Here are the key news stories impacting Diploma this week:

• Positive Sentiment: Berenberg Bank reiterated its buy rating on Diploma PLC and lifted its price target to GBX 9,000, reinforcing a positive analyst view on the stock’s valuation and growth prospects. Broker views source
• Positive Sentiment: Several senior insiders bought shares, including Mandy Gradden (1,000 shares), Wilson Ng (424 shares), and Katie Bickerstaffe (multiple purchases), which investors often view as a sign management believes the stock is undervalued. TipRanks article
• Neutral Sentiment: An article highlighting Diploma as a potential long-term compounding stock added visibility, but it did not include new company-specific financial results or guidance. Yahoo Finance article

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.